Literature DB >> 29506129

A Universal Influenza Vaccine: The Strategic Plan for the National Institute of Allergy and Infectious Diseases.

Emily J Erbelding1,2, Diane J Post1,2, Erik J Stemmy1,2, Paul C Roberts1,2, Alison Deckhut Augustine1,3, Stacy Ferguson1,3, Catharine I Paules1, Barney S Graham1,4, Anthony S Fauci1.   

Abstract

A priority for the National Institute of Allergy and Infectious Diseases is development of a universal influenza vaccine providing durable protection against multiple influenza strains. NIAID will use this strategic plan as a foundation for future investments in influenza research.

Entities:  

Mesh：

Substances：

Year:  2018        PMID： 29506129      PMCID： PMC6279170          DOI： 10.1093/infdis/jiy103

Source DB:  PubMed          Journal:  J Infect Dis        ISSN： 0022-1899            Impact factor:   5.226


  19 in total

Review 1.  Immune history and influenza virus susceptibility.

Authors:  Sarah Cobey; Scott E Hensley
Journal:  Curr Opin Virol       Date:  2017-01-12       Impact factor: 7.090

Review 2.  Influenza.

Authors:  Catharine Paules; Kanta Subbarao
Journal:  Lancet       Date:  2017-03-13       Impact factor: 79.321

3.  The Pathway to a Universal Influenza Vaccine.

Authors:  Catharine I Paules; Hilary D Marston; Robert W Eisinger; David Baltimore; Anthony S Fauci
Journal:  Immunity       Date:  2017-10-17       Impact factor: 31.745

4.  Potent protection against H5N1 and H7N9 influenza via childhood hemagglutinin imprinting.

Authors:  Katelyn M Gostic; Monique Ambrose; Michael Worobey; James O Lloyd-Smith
Journal:  Science       Date:  2016-11-11       Impact factor: 47.728

Review 5.  Systems vaccinology: probing humanity's diverse immune systems with vaccines.

Authors:  Bali Pulendran
Journal:  Proc Natl Acad Sci U S A       Date:  2014-08-18       Impact factor: 11.205

6.  Vaccine-Induced Antibodies that Neutralize Group 1 and Group 2 Influenza A Viruses.

Authors:  M Gordon Joyce; Adam K Wheatley; Paul V Thomas; Gwo-Yu Chuang; Cinque Soto; Robert T Bailer; Aliaksandr Druz; Ivelin S Georgiev; Rebecca A Gillespie; Masaru Kanekiyo; Wing-Pui Kong; Kwanyee Leung; Sandeep N Narpala; Madhu S Prabhakaran; Eun Sung Yang; Baoshan Zhang; Yi Zhang; Mangaiarkarasi Asokan; Jeffrey C Boyington; Tatsiana Bylund; Sam Darko; Christopher R Lees; Amy Ransier; Chen-Hsiang Shen; Lingshu Wang; James R Whittle; Xueling Wu; Hadi M Yassine; Celia Santos; Yumiko Matsuoka; Yaroslav Tsybovsky; Ulrich Baxa; James C Mullikin; Kanta Subbarao; Daniel C Douek; Barney S Graham; Richard A Koup; Julie E Ledgerwood; Mario Roederer; Lawrence Shapiro; Peter D Kwong; John R Mascola; Adrian B McDermott
Journal:  Cell       Date:  2016-07-21       Impact factor: 41.582

7.  Cytotoxic T-cell immunity to influenza.

Authors:  A J McMichael; F M Gotch; G R Noble; P A Beare
Journal:  N Engl J Med       Date:  1983-07-07       Impact factor: 91.245

8.  Dimeric FcγR Ectodomains as Probes of the Fc Receptor Function of Anti-Influenza Virus IgG.

Authors:  Bruce D Wines; Hillary A Vanderven; Sandra E Esparon; Anne B Kristensen; Stephen J Kent; P Mark Hogarth
Journal:  J Immunol       Date:  2016-07-06       Impact factor: 5.422

9.  Human Tissue-Resident Memory T Cells Are Defined by Core Transcriptional and Functional Signatures in Lymphoid and Mucosal Sites.

Authors:  Brahma V Kumar; Wenji Ma; Michelle Miron; Tomer Granot; Rebecca S Guyer; Dustin J Carpenter; Takashi Senda; Xiaoyun Sun; Siu-Hong Ho; Harvey Lerner; Amy L Friedman; Yufeng Shen; Donna L Farber
Journal:  Cell Rep       Date:  2017-09-19       Impact factor: 9.995

10.  Deep Sequencing Reveals Potential Antigenic Variants at Low Frequencies in Influenza A Virus-Infected Humans.

Authors:  Jorge M Dinis; Kelsey R Florek; Omolayo O Fatola; Louise H Moncla; James P Mutschler; Olivia K Charlier; Jennifer K Meece; Edward A Belongia; Thomas C Friedrich
Journal:  J Virol       Date:  2016-01-06       Impact factor: 5.103
View more
  160 in total

1.  Immunodominance and Antigenic Variation of Influenza Virus Hemagglutinin: Implications for Design of Universal Vaccine Immunogens.

Authors:  Seth J Zost; Nicholas C Wu; Scott E Hensley; Ian A Wilson
Journal:  J Infect Dis       Date:  2019-04-08       Impact factor: 5.226

2.  Influenza Vaccines: Good, but We Can Do Better.

Authors:  Catharine I Paules; Anthony S Fauci
Journal:  J Infect Dis       Date:  2019-04-08       Impact factor: 5.226

3.  Exploring the potential public health benefits of universal influenza vaccine.

Authors:  Jay V DePasse; Mary Patricia Nowalk; Kenneth J Smith; Jonathan M Raviotta; Eunha Shim; Richard K Zimmerman; Shawn T Brown
Journal:  Hum Vaccin Immunother       Date:  2019-06-18       Impact factor: 3.452

4.  Chimeric hemagglutinin vaccine elicits broadly protective CD4 and CD8 T cell responses against multiple influenza strains and subtypes.

Authors:  Hsin-Yu Liao; Shih-Chi Wang; Yi-An Ko; Kuo-I Lin; Che Ma; Ting-Jen Rachel Cheng; Chi-Huey Wong
Journal:  Proc Natl Acad Sci U S A       Date:  2020-07-15       Impact factor: 11.205

5.  Beyond Disease Severity: The Impact of Obesity on Influenza A Virus Shedding.

Authors:  Stacey Schultz-Cherry
Journal:  J Infect Dis       Date:  2018-09-22       Impact factor: 5.226

Review 6.  VH1-69 antiviral broadly neutralizing antibodies: genetics, structures, and relevance to rational vaccine design.

Authors:  Fang Chen; Netanel Tzarum; Ian A Wilson; Mansun Law
Journal:  Curr Opin Virol       Date:  2019-03-16       Impact factor: 7.090

Review 7.  Tfh cell response in influenza vaccines in humans: what is visible and what is invisible.

Authors:  Hideki Ueno
Journal:  Curr Opin Immunol       Date:  2019-03-25       Impact factor: 7.486

8.  Universal Influenza Virus Vaccines That Target the Conserved Hemagglutinin Stalk and Conserved Sites in the Head Domain.

Authors:  Florian Krammer; Peter Palese
Journal:  J Infect Dis       Date:  2019-04-08       Impact factor: 5.226

9.  Germline-Encoded Affinity for Cognate Antigen Enables Vaccine Amplification of a Human Broadly Neutralizing Response against Influenza Virus.

Authors:  Maya Sangesland; Larance Ronsard; Samuel W Kazer; Julia Bals; Seyhan Boyoglu-Barnum; Ashraf S Yousif; Ralston Barnes; Jared Feldman; Maricel Quirindongo-Crespo; Patrick M McTamney; Daniel Rohrer; Nils Lonberg; Bryce Chackerian; Barney S Graham; Masaru Kanekiyo; Alex K Shalek; Daniel Lingwood
Journal:  Immunity       Date:  2019-09-25       Impact factor: 31.745

10.  Impact of Protein Glycosylation on the Design of Viral Vaccines.

Authors:  Kathleen Schön; Bernd Lepenies; Guillaume Goyette-Desjardins
Journal:  Adv Biochem Eng Biotechnol       Date:  2021       Impact factor: 2.635
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.